These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154 [TBL] [Abstract][Full Text] [Related]
3. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay. Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155 [TBL] [Abstract][Full Text] [Related]
4. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome. Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033 [TBL] [Abstract][Full Text] [Related]
5. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited. Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627 [TBL] [Abstract][Full Text] [Related]
6. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422 [TBL] [Abstract][Full Text] [Related]
7. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
12. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies. Lardone RD; Alaniz ME; Irazoqui FJ; Nores GA J Neuroimmunol; 2006 Apr; 173(1-2):174-9. PubMed ID: 16376437 [TBL] [Abstract][Full Text] [Related]
13. Results of testing for anti-GM1 antibodies. McCombe PA; Wilson R; Prentice RL J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617 [TBL] [Abstract][Full Text] [Related]
14. Pure motor relapsing Guillain-Barré syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer. Lagrange E; Veran O; Besson G Eur J Neurol; 2007 Dec; 14(12):e7. PubMed ID: 18028186 [No Abstract] [Full Text] [Related]
15. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease. Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341 [TBL] [Abstract][Full Text] [Related]
16. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Pestronk A; Choksi R Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910 [TBL] [Abstract][Full Text] [Related]
17. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications. Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116 [TBL] [Abstract][Full Text] [Related]
18. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome. Lardone RD; Yuki N; Irazoqui FJ; Nores GA Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965 [TBL] [Abstract][Full Text] [Related]
19. Seroconversion of anti-GM1 antibodies in patients with amyotrophic lateral sclerosis. Haggiag S; Steiner-Birmanns B; Wirguin I; Sicsic C; Brenner T; Steiner I Neurology; 2004 Aug; 63(4):755-6. PubMed ID: 15326266 [No Abstract] [Full Text] [Related]
20. High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies. Lopez PH; Villa AM; Sica RE; Nores GA J Neuroimmunol; 2002 Jul; 128(1-2):69-76. PubMed ID: 12098512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]